首页> 外文期刊>Military Medicine: Official Journal of AMSUS, The Society of the Federal Health Agencies >A NATO Guide for Assessing Deployability for Military Personnel With Chronic Medical Conditions: Medical Fitness for Expeditionary Missions, Task Group 174, Human Factors, and Medicine Panel
【24h】

A NATO Guide for Assessing Deployability for Military Personnel With Chronic Medical Conditions: Medical Fitness for Expeditionary Missions, Task Group 174, Human Factors, and Medicine Panel

机译:北约评估具有慢性医疗条件的军事人员的部署能力的指南:远征任务的医疗适应性,任务组174,人为因素和医学小组

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Each time a deployed military member has an exacerbation of a pre-existing chronic disease there is a potential risk to mission success, individual health, and the safety of the unit. Currently, North Atlantic Treaty Organization (NATO) member nations employ different approaches to assessing an individual's medical fitness for deployment. Objective: To set the minimum medical standards for NATO deployments. Methods: A seven nation task group met periodically from 2008 to 2012 to develop guidelines for frontline military physicians to assess medical fitness for deployment. Results: A medical deployment guide for 31 specific diseases/conditions using a rational, standardized and algorithmic approach based on a red-yellow-green risk stratification. Conclusions: If adopted as a NATO policy, this guide could then be kept up-to-date through a process that allows nations to track individuals with known chronic disease who were deployed into a theater of operations, allowing the guide to become increasingly evidence-based, and also more accurate in quantifying the risk of exacerbation based on individual and disease characteristics, as well as the nature and length of the deployment.
机译:背景:每当部署的军事人员加重已有的慢性病时,都会对任务成功,个人健康和单位安全造成潜在风险。当前,北大西洋公约组织(NATO)成员国采用不同的方法来评估个人的医疗适应性。目标:为北约部署设定最低医疗标准。方法:一个由七个国家组成的任务组从2008年至2012年定期开会,以制定准则,供一线军事医师评估部署的医疗条件。结果:基于红黄绿风险分层的合理,标准化和算法方法针对31种特定疾病/状况的医疗部署指南。结论:如果被采纳为北约政策,则该指南可以通过一个流程来保持最新状态,该流程允许各国追踪部署在战区的已知慢性病患者,从而使该指南越来越成为证据,可以根据个人和疾病特征以及部署的性质和持续时间更准确地量化加重的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号